Infinity Pharmaceuticals, Inc. (INFI) Posts Q3 EPS of 52c; Guides FY12 Sales Below
Tweet Send to a Friend
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q3 EPS of $0.52 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
